Recludix Pharma presents new STAT3 and STAT6 inhibitors
Sep. 21, 2023
Recludix Pharma Inc. has divulged signal transducer and activator of transcription 3 (STAT3) and 6 (STAT6) inhibitors reported to be useful for the treatment of cancer and inflammation.